BACKGROUND: Androgenetic diploid cells confined to the placenta have recently been reported in several cases of normally developed fetuses in association with placental mesenchymal dysplasia (PMD). METHODS AND RESULTS: We investigated two singleton, mildly growth-restricted, female pregnancies ascertained on the basis of PMD. One case had liver hemangiomas and both infants had multiple skin hemangiomas. Post-natal development was normal. Molecular marker analysis confirmed the diagnosis of androgenetic and normal mixed cell populations in the placenta. Both cases derived from a single maternal genome (M1) and two distinct paternal genomes (P1 and P2). In one case, the androgenetic cell population contained both paternal genomes (P1P2), with one shared in common with the biparental (M1P1) population. In the second case, the androgenetic lineage showed complete homozygosity (P2P2) for a paternal genome not common to the biparental cell population. CONCLUSION: These new PMD cases help to define the range of possible clinical presentations of androgenetic/biparental mosaicism or chimerism. Placentas with androgenetic/biparental chimeric cell populations may derive from a single tri-pronuclear (3PN) zygote in which one or more parental genomes are not equally apportioned to the daughter cells in the first cell division.
BACKGROUND: Androgenetic diploid cells confined to the placenta have recently been reported in several cases of normally developed fetuses in association with placental mesenchymal dysplasia (PMD). METHODS AND RESULTS: We investigated two singleton, mildly growth-restricted, female pregnancies ascertained on the basis of PMD. One case had liver hemangiomas and both infants had multiple skin hemangiomas. Post-natal development was normal. Molecular marker analysis confirmed the diagnosis of androgenetic and normal mixed cell populations in the placenta. Both cases derived from a single maternal genome (M1) and two distinct paternal genomes (P1 and P2). In one case, the androgenetic cell population contained both paternal genomes (P1P2), with one shared in common with the biparental (M1P1) population. In the second case, the androgenetic lineage showed complete homozygosity (P2P2) for a paternal genome not common to the biparental cell population. CONCLUSION: These new PMD cases help to define the range of possible clinical presentations of androgenetic/biparental mosaicism or chimerism. Placentas with androgenetic/biparental chimeric cell populations may derive from a single tri-pronuclear (3PN) zygote in which one or more parental genomes are not equally apportioned to the daughter cells in the first cell division.
Authors: Daniel A King; Wendy D Jones; Yanick J Crow; Anna F Dominiczak; Nicola A Foster; Tom R Gaunt; Jade Harris; Stephen W Hellens; Tessa Homfray; Josie Innes; Elizabeth A Jones; Shelagh Joss; Abhijit Kulkarni; Sahar Mansour; Andrew D Morris; Michael J Parker; David J Porteous; Hashem A Shihab; Blair H Smith; Katrina Tatton-Brown; John L Tolmie; Maciej Trzaskowski; Pradeep C Vasudevan; Emma Wakeling; Michael Wright; Robert Plomin; Nicholas J Timpson; Matthew E Hurles Journal: Hum Mol Genet Date: 2015-01-29 Impact factor: 6.150
Authors: Aspasia Destouni; Masoud Zamani Esteki; Maaike Catteeuw; Olga Tšuiko; Eftychia Dimitriadou; Katrien Smits; Ants Kurg; Andres Salumets; Ann Van Soom; Thierry Voet; Joris R Vermeesch Journal: Genome Res Date: 2016-04-12 Impact factor: 9.043
Authors: Sjors Middelkamp; Helena T A van Tol; Diana C J Spierings; Sander Boymans; Victor Guryev; Bernard A J Roelen; Peter M Lansdorp; Edwin Cuppen; Ewart W Kuijk Journal: Sci Adv Date: 2020-04-15 Impact factor: 14.136
Authors: Tine De Coster; Heleen Masset; Olga Tšuiko; Maaike Catteeuw; Yan Zhao; Nicolas Dierckxsens; Ainhoa Larreategui Aparicio; Eftychia Dimitriadou; Sophie Debrock; Karen Peeraer; Marta de Ruijter-Villani; Katrien Smits; Ann Van Soom; Joris Robert Vermeesch Journal: Genome Biol Date: 2022-10-03 Impact factor: 17.906